Placeholder Banner

BIO Testifies to House Agriculture Subcommittee on the Next Farm Bill

March 9, 2017

BIO President & CEO Jim Greenwood testified in front of the U.S. House Committee on Agriculture Subcommittee on Commodity Exchanges, Energy, and Credit at a hearing titled, The Next Farm Bill: Examining Rural Development & Energy Programs.

BIO supports public policies – including government funding for key agencies and programs – to unleash scientific innovation and grow the bioeconomy. BIO urged the subcommittee to ensure the Farm Bill energy title can unleash the potential growth of the bioeconomy, which can create tens of thousands of more jobs in rural America and promote billions of dollars of additional economic activity.

In the testimony, BIO discussed the need to revitalize rural economies and the value of the bio-based economy, and made recommendations for the next Farm Bill.

Download Full Comments Below
BIO-Jim-Greenwood-The-Next-Farm-Bill-Examining-Rural-Development-and-Energy-Programs
Download full comments below:
Discover More
Dear Colleagues,This month marks my one-year anniversary as BIO’s CEO. Like most of us in biotech, this post has been a labor of love. At no time in my 25-year career in this industry have I ever witnessed such awe-inspiring science. Today, we…
Re: BIO Comments on Office of Management and Budget (OMB) Statistical Policy Directive No. 8 North American Industry Classification System (NAICS)-Request forComments on Possible Revisions for 2027 (USBC–2024–0032)Dear Ms. Orvis,The Biotechnology…
Under the 340B program, participating manufacturers must offer 340B pricing on their covered outpatient drugs by covered entities, as a condition of having those drugs federally payable under Medicare Part B and Medicaid. Critically, Congress…